ArticleClinical oncology (Royal College of Radiologists (Great Britain))2022

In Response to: 'Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy?' by Ostler et al. and 'Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy - No' by Macbeth and Hughes-Davies.

I Phillips et al.PubMed ↗Publisher ↗

No numbers read from the abstract.